原名「台灣學術線上」
包含TAO期刊庫 + TAO書籍庫 + 論文 + 史料文獻
首頁 | 關於TAO | 瀏覽 | 進階查詢 | 參考工具 | 會員服務 | 已購專書 | RSS服務 | 電子報 | FAQ  
查詢範圍:
   
查詢模式:
熱門查詢詞:
dvd婦女面對子宮內胎兒死背板EVA一體化封裝湯愛玉
   
   
   
     
   
 
項次 書目
1
題名:Postoperative Radiotherapy for Malignant Parotid Gland Tumors     (14點)
惡性腮腺腫瘤之手術後放射線治療
著者:Li-Ly Wang(王麗鈴) ;Jian-Sheng Jan(詹建勝) ;Jih-Ching Lin(林進清) ;Hsien-Chun Tseng(曾顯群) ;Yih-Chyang Weng(翁益強) ;Chung-Shuh Kao(高忠恕)
出版地區:台灣
出版城市:台北市
學科:醫學綜合
關鍵字:惡性腮腺腫瘤 ; 手術後放射線治療 ; Malignant parotid gland tumors ; Postoperative radiotherapy
刊名:Therapeutic Radiology and Oncology
頁碼:109-115
語言:英語
摘要: 中文摘要PDF ; 英文摘要PDF

目的: 針對惡性臆腺腫瘤之手術後放射線治療, 評估其治療結果, 並分析其預後因子。 材料與方法: 自1 9 8 4 年1 月至1 9 9 3 年1 2 月, 共有4 2 位罹患惡性臆朦腫瘤之病患於本科接受完整之放射線治療。其中, 28 位病患接受手術後放射線治療, 男性占12 位, 女性1 6 位,年齡介於1 5 至7 8歲之間(中間值: 46 歲) 。腫瘤分期第一期至第四期分別為8 位、6 位、3位及1 1位病患。依據組織學型態, 共包括黏液上皮細胞癌: 8 位, 腺癌6 位, 上皮細胞癌: 3 位, 腺囊癌: 3 位, 惡性混合腫瘤: 2 位, 腺狀扁平細胞癌﹒2 位, 未分化細胞癌: 2位, 腺泡細胞癌1位, 類淋巴扁平細胞癌: 1 位。大部份病患接受C o-60 治療, 使用單倒模形濾板照野及局部電子射束補強。放射線治療劑量為5 7 至7 2 Gy (中間值: 60 Gy ) 。 結果: 追踩至1 9 9 7 年1 月, 五年之整體存活率為7 8 % ' 十年為6 5 % 。五年之局部控制率為89 % 。三位病患於3-12 個月發生局部復發, 六位病患在3- 69 個月產生遠端轉移, 其中二位同時合併局部與遠端復發。大部份失敗發生於手術後一年內。腫瘤分期第一期之五年存活率為100% ' 第二期為8 3 % . 第三期為1 0 0 % ' 第四期為5 5 % 。淋巴腺轉移、腫瘤分期及組織學型態,為影響預後重要之因子( P < 0 . 0 5 ) 。 結論: 手術後放射線治療可有效消誠顯微之殘餘腫瘤, 並可得到良好之局部控制率。影響預後的重要因素有淋巴腺轉移、腫瘤分期及組織學型態。淋巴腺轉移、腫瘤分期第四期、與腺癌真有較差的預後。
Purpose: To evaluate the treatment results and analyze the prognostic factors of postoperative radiotherapy for malignant parotid gland tumors. Materials and Methods: From January 1984 to December 1993, 42 patients with malignant parotid gland tumors received a complete course of radiotherapy at Taichung Veterans General Hospital. Twenty-eight of the 42 patients were treated with postoperative radiotherapy. There were 12 males and 16 females, between 15 and 78 years old (median: 46). The numbers of the patients in stage I to IV were 8, 6, 3, and 11, respectively. The types of cancer included mucoepidermoid carcinoma,8; adenocarcinoma,6; epidermoid carcinoma,3; adenoid cystic carcinoma,3 ; malignant mixed tumor,2 ; adenosquamous cell carcinoma,2; undifferentiated carcinoma,2; acinic cell carcinoma,1; and Iymphoepithelioma-Iike carcinoma,1. Most patients were treated with Co-60 using unilateral wedge pair fields and an electron beam local boost. The dose of radiotherapy was 57 to 72 Gy (median: 60 Gy). Results: The patients were followed up till January 1997. The 5-year and 10-year overall survival rates were 78% and 65%, respectively. The 5-year local control rate was 89%. Three patients developed local recurrences at 3-12 months, 6 patients developed distant metastases at 3-69 months, and 2 had combined local recurrences and distant metastases. Most failure occurred in the first year after surgery. Five-year survival rates for stage I to IV were 100%, 83%, 100%, and 55%, respectively. Lymph node involvement, stage, and histology were the significant prognostic factors (P<0.05). Conclusions: Postopera tive radiothe rapy was effect ive in eradicating microscopic residual tumors and yielded a good local control rate. Lymph node involvement, stage, and histology were the significant prognostic factors. Lymph node involvement, stage IV tumors, and adenocarcinoma indicated a relatively poor prognosis.


    

本卷期目次
Therapeutic Radiology and Oncology
組織挿植式微波天線陣列熱療系統之假體研究/ 熊佩韋許文林蘇振隆紀瑞峻施榕平
Leipzig Applicators之劑量特性/ 黃英明郭珍妮陳海雯王裕文
病毒檢驗在腫瘤診斷與治療上的應用/ 周寬基張錦霞周絢蘭曾文瑟陳光耀
鼻咽癌與治療前EB病毒VCA抗體指數的關係/ 陳建勳林立青胡渝昌劉文山張慶雄
Radiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and NeckRadiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and Neck/ Chung-Shuh KaoJian-Sheng JanChing-ilsiung ChangJin-Ching LinHsien-Chun TsengYih-Chyang Weng
硫酸亞鐵膠體劑量計在放射治療應用之原理與探討/ 羅濟慶李俊信
Treatment Results of Malignant Lymphoma of Nasopharynx at National Taiwan University Hospital/ Louis Tak LuiWei-Chung HsuNa-Na ChungPo-Ming WangLai-Lei TingRuey-Long Hong
婦女腹股淋巴結之放射治療技術/ 張東杰陳麗惠李紳豪湯國政
Endocrine Dysfunction in Patients with Nasopharyngeal Carcinoma after Radiotherapy -A Prospective Study with 10 Years Follow-Up/ Chun-Chieh WangJoseph T. ChangJen-Der LinSimon G. TangJi-Hong Hong
晚期鼻咽癌同步化學放射治療之研究-臺中榮總之經驗/ 林進清詹建勝曾顯群翁益強高忠恕王麗鈴
鼻咽癌與治療前EB病毒VCA抗體指數的關係/ 陳建勳林立青胡渝昌劉文山張慶雄
Postoperative Radiotherapy for Malignant Parotid Gland Tumors/ Li-Ly WangJian-Sheng JanJih-Ching LinHsien-Chun TsengYih-Chyang WengChung-Shuh Kao
Postoperative Radiotherapy for Malignant Parotid Gland Tumors/ 王麗鈴詹建勝林進清曾顯群翁忠恕高忠恕
Endocrine Dysfunction in Patients with Nasopharyngeal Carcinoma after Radiotherapy-A Prospective Study with 10 Years Follow-Up/ Chun-Chieh WangJoseph T. ChangJen-Der LinSimon G. TangJi-Hong Hong
婦女腹股淋巴結之放射治療技術/ 張東杰陳麗惠李紳豪湯國政
Leipzig Applicators之劑量特性/ 黃英明郭珍妮陳海雯王裕文
硫酸亞鐵膠體劑量計在放射治療應用之原理與探討/ 羅濟慶李俊信
組織插植式微波天線陣列熱療系統之假體研究/ 熊佩韋許文林蘇振隆紀瑞峻施榕平
病毒檢驗在腫瘤診斷與治療上的應用/ 周寬基張錦霞周絢蘭曾文瑟陳光耀
Radiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and Neck/ Chung-Shuh KaoJian-Sheng JanChing-Hsiung ChangJin-Ching LinHsien-Chun TsengYih-Chyang Weng
Treatment Results of Malignant Lymphoma of Nasopharynx at National Taiwan University Hospital/ Louis Tak LuiWei-Chung HsuNa-Na ChungPo-Ming WangLai-Lei TingRuey-Long Hong
晚期鼻咽癌同步化學放射治療之研究--臺中榮總之經驗/ 林進清唐建勝曾顯群翁益強高忠恕王麗鈴
 
   
 
   

與TAO合作 | 隱私與版權聲明 | 聯絡方式 | 下載Adobe Reader
地址:台北市中正區(100)北平東路30-12號3樓
電話:(02)2393-6968 傳真:(02)2393-6877
Email: service@wordpedia.com
Wordpedia Family: 學校、企業版入口 | 遠流影音館
Copyright©2011 Wordpedia Co., Ltd. All Rights Reserved.